Artelo Biosciences (ARTL) vs PMGC (ELAB)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
PMGC is the larger company by market cap ($2.5 million vs $1.8 million), about 1.4 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ARTL | ELAB |
|---|---|---|
| Share price | $3.26 | $3.08 |
| Market cap | $1.79M | $2.49M |
| 1-day change | -3.26% | -0.96% |
| EPS (TTM) | $-129.22 | $-1,748.36 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $179.19 | $2,671.20 |
| 52-week low | $3.19 | $2.59 |
| Distance from 52-week high | -98.18% | -99.88% |
| Average volume | 480.92K | 127.38K |
| Shares outstanding | 547.77K | 809.58K |
| Employees | 7 | 32 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Artelo Biosciences
ARTL stock →Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, develops and commercializes therapeutics that target lipid-signaling pathways in the United States. The company's product candidate pipeline includes ART27.13, a synthetic dual cannabinoid G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of cancer-related anorexia; and ART12.11, a cocrystal composition of cannabidiol and tetramethylpyrazine for the treatment anxiety, depression, post-traumatic stress disorder PTSD, epilepsy and insomnia, and other potential indications.
Health Care · Biotechnology: Pharmaceutical Preparations · 7 employees
About PMGC
ELAB stock →PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining.
Health Care · Biotechnology: Pharmaceutical Preparations · 32 employees
ARTL vs ELAB FAQ
Which is bigger, Artelo Biosciences or PMGC?
PMGC (ELAB) is larger, with a market capitalization of $2.49M compared with $1.79M for Artelo Biosciences (ARTL).
Are Artelo Biosciences and PMGC in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.